Literature DB >> 22549695

Canal switch after canalith repositioning procedure for benign paroxysmal positional vertigo.

Giant C Lin1, Gregory J Basura, Hiu Tung Wong, Katherine D Heidenreich.   

Abstract

Canal switch is a complication following canalith repositioning procedure (CRP) for posterior canal benign paroxysmal positional vertigo (BPPV). Instead of being returned to the utricle, the loose otoconia migrate into the superior or horizontal semicircular canal. Patients remain symptomatic, and treatment can be ineffective unless the switch is recognized and additional repositioning maneuvers directed toward the appropriate semicircular canal are performed. This report provides the first videographic documentation of canal switch involving conversion of unilateral posterior semicircular canal BPPV to geotropic horizontal canalithiasis.
Copyright © 2012 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22549695     DOI: 10.1002/lary.23315

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Canal switch and re-entry phenomenon in benign paroxysmal positional vertigo: difference between immediate and delayed occurrence.

Authors:  F Dispenza; A DE Stefano; C Costantino; D Rando; M Giglione; R Stagno; E Bennici
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-04       Impact factor: 2.124

2.  Efficacy of SRM-IV Vestibular Function Diagnosis and Treatment System in Treating Benign Paroxysmal Positional Vertigo.

Authors:  Nuan Wang; Hao Zhou; Hongli Huang; Deqin Geng; Xiuhua Yang; Chunyu Yu; Di Shi
Journal:  Iran J Public Health       Date:  2018-05       Impact factor: 1.429

3.  Simulation Study of Canal Switching in BPPV.

Authors:  Shuzhi Wu; Jianxin Li; Mi Zhou; Xiaokai Yang
Journal:  Front Neurol       Date:  2022-07-13       Impact factor: 4.086

4.  Characteristics of assessment and treatment in Benign Paroxysmal Positional Vertigo (BPPV).

Authors:  Laura Power; Katherine Murray; David J Szmulewicz
Journal:  J Vestib Res       Date:  2020       Impact factor: 2.354

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.